Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Health Affairs (Project Hope)|January 8, 2019
The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of DrugsInmaculada Hernandez, Chester B Good, David M Cutler, et al.
American Heart Journal Plus : Cardiology Research and Practice|February 9, 2022
Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysisInmaculada Hernandez, Nico Gabriel, Meiqi He, et al.
Journal of Managed Care & Specialty Pharmacy|September 19, 2024
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025Emma M Cousin, Sean D Sullivan, Ryan N Hansen, et al.
JAMA Network Open|June 12, 2023
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular DiseaseJing Luo, Robert Feldman, Katherine Callaway Kim, et al.
Expert Opinion on Pharmacotherapy|March 7, 2018
A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infectionsNeil J Turco, Sandra L Kane-Gill, Inmaculada Hernandez, et al.
JAMA Neurology|August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part DAlvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Journal of the American Pharmacists Association : Japha|August 14, 2022
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysisLucas A Berenbrok, Shangbin Tang, Nico Gabriel, et al.
Journal of Molecular Endocrinology|June 9, 2007
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activityMichael D Rudd, Ignacio Gonzalez-Robayna, Inmaculada Hernandez-Gonzalez, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 16, 2007
Regulation of the expression of prostate apoptosis response protein 4 (Par-4) in rat granulosa cellsInmaculada Hernandez Gonzalez, Pino Santana, Ignacio Gonzalez-Robayna, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillationJingchuan Serena Guo, Meiqi He, Nico Gabriel, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Health Affairs (Project Hope)|January 8, 2019
The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of DrugsInmaculada Hernandez, Chester B Good, David M Cutler, et al.
American Heart Journal Plus : Cardiology Research and Practice|February 9, 2022
Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysisInmaculada Hernandez, Nico Gabriel, Meiqi He, et al.
Journal of Managed Care & Specialty Pharmacy|September 19, 2024
Drugs anticipated to be selected for the Medicare Drug Price Negotiation Program in 2025Emma M Cousin, Sean D Sullivan, Ryan N Hansen, et al.
JAMA Network Open|June 12, 2023
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular DiseaseJing Luo, Robert Feldman, Katherine Callaway Kim, et al.
Expert Opinion on Pharmacotherapy|March 7, 2018
A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infectionsNeil J Turco, Sandra L Kane-Gill, Inmaculada Hernandez, et al.
JAMA Neurology|August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part DAlvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Journal of the American Pharmacists Association : Japha|August 14, 2022
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysisLucas A Berenbrok, Shangbin Tang, Nico Gabriel, et al.
Journal of Molecular Endocrinology|June 9, 2007
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activityMichael D Rudd, Ignacio Gonzalez-Robayna, Inmaculada Hernandez-Gonzalez, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 16, 2007
Regulation of the expression of prostate apoptosis response protein 4 (Par-4) in rat granulosa cellsInmaculada Hernandez Gonzalez, Pino Santana, Ignacio Gonzalez-Robayna, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillationJingchuan Serena Guo, Meiqi He, Nico Gabriel, et al.
Pageof 19